⏰ Last chance! Join Premium for $20/month before it increases to $49/month.
US Stocks
RAPP

Rapport Therapeutics, Inc. Common Stock

$24.36
+0.68 (+2.87%)

Volume:

562.385K ($13.70M)
#2230 Volume#2064 Dollar Volume

Market Capitalization:

$1.17B
#2350 Market Cap

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Rapport Therapeutics Market Segments

Regular Trading Hours

+0.64(+2.70%)
Open$23.72
Close$24.36
Low$22.95
Low Change-0.77 (-3.25%)
High$24.53
High Change+0.81 (+3.41%)
Range$1.58
Volume558.666K
Dollar Volume$13.61M

Premarket

-0.21(-0.89%)
Open$23.60
Close$23.39
Low$23.39
Low Change-0.21 (-0.89%)
High$23.70
High Change+0.10 (+0.42%)
Range$0.31
Volume3.719K
Dollar Volume$86.99K

Overnight

*No Trades in Segment

After Hours Yesterday

-0.61(-2.57%)
Open$23.72
Close$23.11
Low$23.10
Low Change-0.62 (-2.60%)
High$23.72
High Change+0.00 (+0.00%)
Range$0.62
Volume142.418K
Dollar Volume$3.29M

Regular Trading Hours Yesterday

-1.96(-7.64%)
Open$25.64
Close$23.68
Low$23.67
Low Change-1.97 (-7.68%)
High$25.67
High Change+0.03 (+0.10%)
Range$2.00
Volume539.922K
Dollar Volume$12.79M

Premarket Yesterday

-0.07(-0.27%)
Open$25.97
Close$25.90
Low$25.50
Low Change-0.47 (-1.81%)
High$26.00
High Change+0.03 (+0.12%)
Range$0.50
Volume2.818K
Dollar Volume$72.99K

Rapport Therapeutics Top Trades

Rapport Therapeutics's top trade so far today returned +6.14%, while the top short trade returned -3.25%.

Unlock the exact entry and exit times, prices, durations, and more top-performing trades with Finsuba Premium. Learn more >>>

Rapport Therapeutics Moving Averages

5 Day Moving Average (SMA5)$25.03
10 Day Moving Average (SMA10)$25.06
20 Day Moving Average (SMA20)$26.76
50 Day Moving Average (SMA50)$34.68
100 Day Moving Average (SMA100)$38.79
200 Day Moving Average (SMA200)$35.62

Rapport Therapeutics Statistics

Average Volume (30 Days)421.44K
P/E Ratio (Current)-10.72
EPS (Current)-$2.86
Dividend Yield0.00%
Free Cash Flow-$97.15M
Cash Ratio2.24
Current Ratio15.72
Quick Ratio15.72
Debt to Equity0.00
Enterprise Value$1.41B
EV to EBITDA-9.22
EV to Sales70.35
Price to Book3.48
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales73.53
Return on Assets-0.30%
Return on Equity-0.32%

Rapport Therapeutics Stock Splits

There have been no stock splits for Rapport Therapeutics (RAPP).

Rapport Therapeutics Dividends

There have been no dividends for Rapport Therapeutics (RAPP).